Hormone replacement therapy and myocardial perfusion in postmenopausal women: Evaluation with positron-emission-tomography;Hormonsubstitution und myokardiale perfusion postmenopausaler frauen: Messung mit positronen-emissions-tomographie

Geburtshilfe und Frauenheilkunde

Volumn 62, Issue 3, 2002, Pages 250-256

  Rattenhuber, Judith ^a   Seifert Klauss, V ^a   Duvernoy, C ^b   Bengel, F ^a   Hoss C ^c   Schwaiger, M ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF MICHIGAN   (United States)

^c Abteilung für Gynäkologie und Geburtshilfe   (Germany)

Author keywords

Heart; Hormone replacement; Perfusion; Positron Emission Tomography; Postmenopause

Indexed keywords

CONJUGATED ESTROGEN; MEDROGESTONE;

ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; FEMALE; HEART MUSCLE PERFUSION; HEMODYNAMICS; HORMONE SUBSTITUTION; HUMAN; POSITRON EMISSION TOMOGRAPHY; POSTMENOPAUSE; STRESS; VASOMOTOR REFLEX;

EID: 0036226214     PISSN: 00165751     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-25225     Document Type: Article

References (26)

1. Positron emission tomography of the heart
2. Long-term estrogen therapy abolishes acute estrogen-induced coronary flow augmentation in postmenopausal women
3. Acute effects of conjugated estrogens on coronary blood flow response to acetylcholine in men
4. Peripheral flow response to transient arterial forearm occlusion does not reflect myocardial perfusion reserve
5. Cardiovascular mortality and non-contraceptive use of estrogen in women: Results from the Lipid Research Clinics Program Follow-up Study
6. Premarin-induced increases in coronary blood and uterine blood flow in nonpregnant sheep
7. Early detection of abnormal coronary flow reserve in asymptomatic men at high risk for coronary artery disease using positron emission tomography
8. Gender differences in myocardial blood flow dynamics: Lipid profile and haemodynamic effects
9. Enzymatic synthesis and organ distribution studies with 13 N-labeled L-glutamic acid
10. Estradiol therapy combined with progesterone and endothelium vasodilation in postmenopausal women
11. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women
12. Acute vascular effects of estrogen in postmenopausal women
13. Effects of estrogen replacement therapy on peripheral vasomotor function in postmenopausal women
14. Postmenopausal hormone therapy and mortality
15. Randomized trial of estrogen plus progestin for secundary prevention of coronary heart disease in postmenopausal women
16. Prospective, randomized controlled study of the effect of hormone replacement therapy on peripheral blood flow velocity in postmenopausal women
17. An automated analysis program for the evaluation of cardiac PET studies: Initial results in the detection and localisation of coronary artery disease using nitrogen-13-ammonia
18. Effects of acute administration of natural progesterone on peripheral vascular responsiveness in healthy postmenopausal women
19. Endothelium independent relaxation of human coronary arteries by 17 beta-estradiol in vitro
20. Validation of nitrogen-13-ammonia tracer kinetic model for quantification of myocardial blood flow using PET
21. Blood flow variations in internal carotid and middle cerebral arteries induced by postmenopausal hormone replacement therapy
22. Alteration in the pulsatility index values of the internal carotid and middle cerebral arteries after suspension of postmenopausal hormone replacement therapy: A randomized crossover study
23. Schützen hormone vor KHK?
24. Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women
25. Myocardial perfusion imaging with PET
26. PET perfusion and vasodilator function after angioplasty for acute myocardial infarction